High-Content Drug Screening With Engineered Musculoskeletal Tissues

Tissue Engineering - Part B: Reviews - United States
doi 10.1089/ten.teb.2009.0445
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

High Content Screening for Drug Discovery From Traditional Chinese Medicine

Chinese Medicine
Alternative MedicinePharmacologyComplementary
2019English

Decoding the Regulatory Landscape of Ageing in Musculoskeletal Engineered Tissues Using Genome-Wide DNA Methylation and RNASeq

PLoS ONE
Multidisciplinary
2016English

Recent Advances Toward Understanding the Role of Transplanted Stem Cells in Tissue-Engineered Regeneration of Musculoskeletal Tissues

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2020English

Multi-Well Engineered Heart Tissue for Drug Screening and Predictive Toxicology

2012English

Design Standards for Engineered Tissues

Biotechnology Advances
Applied MicrobiologyBiotechnologyBioengineering
2013English

High-Content Screening: A New Approach to Easing Key Bottlenecks in the Drug Discovery Process

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
1997English

Automated Microscopy for High-Content RNAi Screening

Journal of Cell Biology
MedicineCell Biology
2010English

The First Automated High Content Screening System

JALA: Journal of the Association for Laboratory Automation
2003English

Integrating Image-Based High-Content Screening With Mouse Models Identifies 5-Hydroxydecanoate as a Neuroprotective Drug for Paclitaxel-Induced Neuropathy

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy